We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Netherlands' Outbreak Management Team (OMT) expressed doubts about whether Johnson & Johnson's single-dose COVID-19 vaccine offers sufficient protection against the Delta variant, reported NL Times.
Exposure to opioid maintenance treatment (OMT) in the womb does not seem to cause additional harm to newborns, according to a study published online in Pharmacology Research & Perspectives.